# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-24T14:33:32.315640
**Route:** OpenRouter + LaTeX
**Paper Hash:** afabc220bf6b66ef
**Tokens:** 15900 in / 951 out
**Response SHA256:** 3b8bba65717408c6

---

No fatal errors detected in the submitted LaTeX source under the four critical categories (Data–Design Alignment, Regression Sanity, Completeness, Internal Consistency).

### 1) Data–Design Alignment (critical)
- **Treatment timing vs. data coverage:** Treatment is June–July 2021 (first full month July/August 2021). Data cover **Jan 2018–Dec 2024**, so treatment occurs well within the data window.
- **Post-treatment observations:** Yes. With data through 2024, both cohorts (July 2021 and August 2021) have substantial post-treatment periods.
- **Treatment definition consistency:** The treatment timing described in text (first full month after termination; two cohorts) matches **Appendix Table \ref{tab:treatment_timing}** and the cohort definition used throughout.

### 2) Regression Sanity (critical)
Checked all reported regression tables:
- **Table \ref{tab:main_results}:** Coefficients and SEs are in plausible ranges for log outcomes; no impossible values (no NA/Inf/NaN; no R² reported, so no R² violations). SEs are not wildly disproportionate to coefficients.
- **Table \ref{tab:robustness}:** Estimates/SEs plausible; no pathological magnitudes.
- **Table \ref{tab:triple_diff}:** Coefficient/SE plausible; no pathological magnitudes.

No fatal regression-output issues found.

### 3) Completeness (critical)
- Regression tables report **standard errors** and **sample sizes/observations** (e.g., Table \ref{tab:main_results} includes “Observations”; Table \ref{tab:triple_diff} includes “Observations”).
- No placeholders like TBD/TODO/XXX/NA in tables or coefficient entries.
- No in-text references to non-existent tables/figures apparent from the LaTeX source (all referenced items have corresponding `\label{...}` blocks).

No fatal incompleteness issues found.

### 4) Internal Consistency (critical)
- Treatment cohort counts are consistent: **26 treated** vs **25 never-treated** jurisdictions; panel size consistent with **51 units × 84 months = 4,284 observations** (matches Table \ref{tab:main_results}).
- Treatment timing statements are consistent across the main text and Appendix timing table.

No fatal internal inconsistencies found.

ADVISOR VERDICT: PASS